Long-Term Hepatitis B Virus Infection Induces Cytopathic Effects in Primary Human Hepatocytes, and Can Be Partially Reversed by Antiviral Therapy.


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
23 02 2022
Historique:
pubmed: 17 2 2022
medline: 8 3 2022
entrez: 16 2 2022
Statut: ppublish

Résumé

Chronic infection of hepatitis B virus (HBV) remains a major health burden worldwide. While the immune response has been recognized to play crucial roles in HBV pathogenesis, the direct cytopathic effects of HBV infection and replication on host hepatocytes and the HBV-host interactions are only partially defined due to limited culture systems. Here, based on our recently developed 5 chemical-cultured primary human hepatocytes (5C-PHHs) model that supports long-term HBV infection, we performed multiplexed quantitative analysis of temporal changes of host proteome and transcriptome on PHHs infected by HBV for up to 4 weeks. We showed that metabolic-, complement-, cytoskeleton-, mitochondrial-, and oxidation-related pathways were modulated at transcriptional or posttranscriptional levels during long-term HBV infection, which led to cytopathic effects and could be partially rescued by early, rather than late, nucleot(s)ide analog (NA) administration and could be significantly relieved by blocking viral antigens with RNA interference (RNAi). Overexpression screening of the dysregulated proteins identified a series of host factors that may contribute to pro- or anti-HBV responses of the infected hepatocytes. In conclusion, our results suggest that long-term HBV infection in primary human hepatocytes leads to cytopathic effects through remodeling the proteome and transcriptome and early antiviral treatment may reduce the extent of such effects, indicating a role of virological factors in HBV pathogenesis and a potential benefit of early administration of antiviral treatment.

Identifiants

pubmed: 35171034
doi: 10.1128/spectrum.01328-21
pmc: PMC8849052
doi:

Substances chimiques

Antiviral Agents 0
entecavir 5968Y6H45M
Guanine 5Z93L87A1R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0132821

Références

Hepatology. 2002 Dec;36(6):1400-7
pubmed: 12447865
Nat Microbiol. 2019 May;4(5):813-825
pubmed: 30833724
Nucleic Acids Res. 2019 Jan 8;47(D1):D1211-D1217
pubmed: 30252093
EBioMedicine. 2018 Sep;35:114-123
pubmed: 30120080
PLoS Pathog. 2016 Feb 18;12(2):e1005438
pubmed: 26891448
PLoS Pathog. 2020 Nov 12;16(11):e1008593
pubmed: 33180834
Gastroenterology. 2019 Jan;156(2):338-354
pubmed: 30243619
Cell Metab. 2019 Sep 3;30(3):539-555.e11
pubmed: 31257153
J Virol. 2018 Sep 12;92(19):
pubmed: 30021897
Oncotarget. 2015 Dec 29;6(42):44877-91
pubmed: 26565721
J Gastroenterol Hepatol. 2008 Aug;23(8 Pt 1):1169-74
pubmed: 18505413
Cell. 2014 Jun 5;157(6):1460-1472
pubmed: 24906157
Cell Physiol Biochem. 2018;45(2):744-760
pubmed: 29414802
Bull Exp Biol Med. 2014 Dec;158(2):268-73
pubmed: 25430651
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Hepatology. 2018 Apr;67(4):1237-1252
pubmed: 29059468
Carcinogenesis. 2020 May 14;41(3):345-357
pubmed: 31175354
Nature. 2019 Mar;567(7747):257-261
pubmed: 30814741
Nat Biotechnol. 2019 Aug;37(8):907-915
pubmed: 31375807
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15655-60
pubmed: 12432097
J Cell Mol Med. 2019 Sep;23(9):5920-5933
pubmed: 31282064
mBio. 2020 Nov 17;11(6):
pubmed: 33203756
Cell Discov. 2021 Nov 2;7(1):105
pubmed: 34725333
Elife. 2012 Nov 13;1:e00049
pubmed: 23150796
J Med Virol. 2010 Jan;82(1):14-22
pubmed: 19950238
Cell Host Microbe. 2015 Oct 14;18(4):409-23
pubmed: 26439863
J Hepatol. 2018 Jul;69(1):25-35
pubmed: 29524530
Nat Med. 2013 Jul;19(7):859-68
pubmed: 23836236
Virology. 1990 Nov;179(1):113-20
pubmed: 2171201
Nat Rev Immunol. 2022 Jan;22(1):19-32
pubmed: 34002067
J Hepatol. 2021 Jul;75(1):74-85
pubmed: 33621634
Antiviral Res. 2020 May;177:104783
pubmed: 32217150
J Immunol. 1997 Jun 15;158(12):5692-7
pubmed: 9190918
J Exp Med. 2000 Apr 17;191(8):1269-80
pubmed: 10770795
Nat Rev Microbiol. 2008 Mar;6(3):211-21
pubmed: 18264117
PLoS Pathog. 2021 Aug 9;17(8):e1009838
pubmed: 34370796
Nat Commun. 2020 Jun 1;11(1):2707
pubmed: 32483149
N Engl J Med. 2005 Jun 30;352(26):2682-95
pubmed: 15987917
Science. 2019 Apr 26;364(6438):399-402
pubmed: 31023926
Gastroenterology. 2009 Feb;136(2):652-62.e3
pubmed: 19041311
Gut. 2018 May;67(5):945-952
pubmed: 29055908
Hepatology. 2021 Feb;73(2):486-502
pubmed: 32333814
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
J Hepatol. 2021 Mar;74(3):535-549
pubmed: 32971137
Nat Commun. 2018 Feb 14;9(1):682
pubmed: 29445209
Gut. 2012 May;61 Suppl 1:i6-17
pubmed: 22504921
Cell Host Microbe. 2018 Sep 12;24(3):447-460.e11
pubmed: 30122656
World J Gastroenterol. 2012 May 28;18(20):2443-51
pubmed: 22654441
J Hepatol. 2018 Jun;68(6):1123-1128
pubmed: 29452204

Auteurs

Wenjing Zai (W)

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan Universitygrid.8547.e, Shanghai, China.

Kongying Hu (K)

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan Universitygrid.8547.e, Shanghai, China.

Jianyu Ye (J)

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan Universitygrid.8547.e, Shanghai, China.

Jiahui Ding (J)

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan Universitygrid.8547.e, Shanghai, China.

Chao Huang (C)

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan Universitygrid.8547.e, Shanghai, China.

Yaming Li (Y)

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan Universitygrid.8547.e, Shanghai, China.

Zhong Fang (Z)

Shanghai Public Health Clinical Centergrid.470110.3, Fudan Universitygrid.8547.e, Shanghai, China.

Min Wu (M)

Shanghai Public Health Clinical Centergrid.470110.3, Fudan Universitygrid.8547.e, Shanghai, China.

Cong Wang (C)

Shanghai Public Health Clinical Centergrid.470110.3, Fudan Universitygrid.8547.e, Shanghai, China.

Jieliang Chen (J)

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan Universitygrid.8547.e, Shanghai, China.
Research Unit of Cure of Chronic Hepatitis B Virus Infection, Chinese Academy of Medical Sciences, Shanghai, China.

Zhenghong Yuan (Z)

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Fudan Universitygrid.8547.e, Shanghai, China.
Research Unit of Cure of Chronic Hepatitis B Virus Infection, Chinese Academy of Medical Sciences, Shanghai, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH